Nuclear Pharmacy eNewsletter
Brought to you by Nuclear Education Online                                                 
In This Issue
$163M to Create Mo-99 in US
Chalk River Reactor News
U.S. Based Mo-99 Accelerator
New Mo-99 Production Technology
P-32 Skin Cancer Treatment
FDG Identifies Effective Soft Tissue Sarcoma Treatment
Creators of Cardiolite Honored
Calendar of Events
Nuclear Facts 
There was not a single adverse reaction reported in over 81,000 administered PET doses.
Silberstein, 1998 
Case of the Month
VQ Scan
50 year old patient presents with progressive shortness of breath.  She has a history of cocaine abuse and CHF.  Continued....

Online Poll
 Have you contacted your representative about their support of the American Medical Isotopes Production Act?
Previous Poll Results
July poll results 
Medical Imaging in the News
Links to recent articles and news reports about medical imaging:
Quick Links...
Join Our Mailing List!
A special thank you to Jill Hernandez, Allison Kroeter, and Clint Ross, UAMS Senior nuclear pharmacy students, for their assistance with this newsletter.
Dear Nuclear Medicine Professional,

Years ago I went to Capitol Hill to lobby on behalf of nuclear pharmacy practice concerning compounding legislation.  I saw first hand that my congressmen truly wanted to hear from their constituents and find out what is important to us.  A personal letter or phone call goes a long way in gaining their support.  I urge you to contact your representative and ask for their support of HR 3276 the American Medical Isotopes Production Act.  Currently there are only two co-sponsors, the more support the bill has the more likely it will be to make it out of committee. 
House Bill Allots $163 Million To Create Medical Isotopes in the U.S.
The American Medical Isotopes Production Act seeks to provide resources and authority to the Department of Energy, in order to bring domestic production of Mo-99 on-line as soon as possible. The bill authorizes $163 million over five years, which fully funds the current DoE cost projection for creating domestic Mo-99 production.  The DoE would be required to use this money to support private sector or research sector projects to establish Mo-99 production.  For more information on the details of the bill, see the full article.
Chalk River, Ontario Reactor Will Remain Closed Until Spring 2010
Idaho Accelerator Center The isotope-producing NRU reactor at Chalk River, Ontario will remain closed until at least the spring of 2010.  This is the third time Crown corporation Atomic Energy of Canada Ltd. has pushed back its estimated restart date since the reactor was taken offline in May.  A decade ago, the United States decided not to build its own isotope reactor based on assurances that Canada had two new nuclear reactor projects underway.  Last May, however, Canada canceled plans to open the new reactors, which left other countries scrambling.  For the full article, click here.

Idaho Accelerator Center

Idaho Accelerator CenterThe Idaho Accelerator Center is looking at ways to use nuclear accelerators instead of reactors to produce medical isotopes.  The center needs $3 to 4 million dollars to show they can produce the medical isotopes. To actually build a plant would cost $10 to 15 million, and another $30 to 50 million dollars to supply the nation with Mo-99. But the investment could mean huge savings in the long run, as well as an increase in supply of medical isotopes.  The Center was recently toured by Senator Jim Risch.

Phoenix Nuclear Labs Produce Mo-99 Without A Reactor
Idaho Accelerator CenterWisconsin based Phoenix Nuclear Labs believes that it can produce Mo-99 without using a reactor.  The process is safer, more sustainable, has almost no long-lived nuclear waste, no risk of an explosive accident, and is about 20 times less expensive to construct than a nuclear reactor.  The core technology has been in use for decades, but now it will be used to improve nuclear medicine.  Read the full article for more information.  
New Skin Cancer Patch Is A Possible Alternative to Surgery
A new study shows that a radioactive skin patch can safely and successfully treat basal cell carcinoma, one of the most common types of skin cancers.  The skin patch delivers radioactive phosphorus-32 and is nontoxic. The path could be an excellent alternative to surgery or radiotherapy in cases where carrying out these treatments is difficult.  Phosphorous-32 poses no external radiation hazards, and its limited range prevents beta radiation from reaching the bone or underlying blood vessels, thus sparing the bone and bone marrow.  Interested?  Learn more.  
FDG Uptake Can Help Identify Effective Chemotherapy Treatment
FDG-PET can provide early detection of a change in tumor size after a patient receives chemotherapy treatment.  While standard methods of measuring tumor size can not detect an early response to chemotherapy treatment, flourine-18 FDG-PET has been shown to measure the effect of neoadjuvant therapy on patients with resectable high-grade soft tissue sarcoma.  For more information, read the full article.
SNM Honors Creators of Imaging Agent for Nuclear Heart Stress Test
Alan Davison, Ph.D.; Alun G. Jones, Ph.D.; and Michael J. Abrams, Ph.D. were presented with SNM's 2009 Georg Charles de Hevesy Nuclear Pioneer Award in Toronto during the 56th Annual Meeting of SNM Each year.  SNM has presented the Georg Charles de Hevesy Nuclear Medicine Pioneer Award every year since 1960 to honor groundbreaking work in the field of nuclear medicine.  De Hevesy received the 1943 Nobel Prize in chemistry and is considered the father of nuclear medicine.  Learn more about Davison, Jones, Abrams, and their achievements.
Calendar of Events
Sept 23-26 2009 World Molecular Imaging Congress, Montreal, Canada
Sept 24-28 Southeastern Chapter - SNM 50th Annual Meeting, Birmingham, Alabama 
Oct 1-2 Eastern Great Lakes Chapter of the SNM Annual Meeting, Niagra Falls, NY
Oct 16-18 Missouri Valley Chapter Annual Meeting, Kansas City, MO
Oct 25-31 Nuclear Science Symposium Medical Imaging Conference, Orlando, FL 
Renal scan
Nicki Hilliard, PharmD, BCNP
Professor of Nuclear Pharmacy
Nuclear Pharmacy Technician Training
Most of nuclear pharmacy technician training is on-the-job training, with little formal education.  Take your technician to the next level with the NEO online training for nuclear pharmacy technicians.  For addtional information call 501-686-6398 or see
Nuclear Education Online